Blog

Phuong Ly-Gallagher: What can be done NOW in the global space to advance care in colorectal cancer

Photo from Phuong Ly-Gallagher/LinkedIn

Jun 11, 2024, 05:36

Phuong Ly-Gallagher: What can be done NOW in the global space to advance care in colorectal cancer

Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at

“’It is better represented in phase III studies but has almost negligible participation in other trial phases.’

As we approach Fight Colorectal Cancer’s next (virtual) Early Onset Think Tank, consider this in what can be done NOW in the global space to advance care in colorectal cancer.”

Quoting

“ASCO2024 LATAM Our analysis showed that the Latin American region is underrepresented in clinical trials. While 7.7% of all cancer cases in 2020 were diagnosed in LATAM, only 3.64% of oncology trials were conducted there. Scope for improvement!”

Read further.
Source: Phuong Ly-Gallagher/LinkedIn and Kamal S. Saini/LinkedIn

advancing cancer care ASCO24 cancer cancer diagnosis rates Cancer research clinical trial participation clinical trial representation colorectal cancer care Early Onset Think Tank Fight Colorectal Cancer Fortrea Inc. global oncology Kamal S. Saini Latin American region LATM OncoDaily Oncology oncology trial disparities oncology trials phase III studies Phuong Ly-Gallagher Research Research Advocate Training and Support (RATS) Manager

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage